Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · IEX Real-Time Price · USD
1.560
-0.070 (-4.29%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $397.70 million as of July 22, 2024. Its market cap has decreased by -44.38% in one year.
Market Cap
397.70M
Enterprise Value
-73.72M
1-Year Change
-44.38%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $397.70M, a decrease of -90.37%. That is a compound annual growth rate of -53.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 397.70M | -18.60% |
| Dec 29, 2023 | 488.60M | -43.53% |
| Dec 30, 2022 | 865.20M | -53.51% |
| Dec 31, 2021 | 1.86B | -54.91% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Esperion Therapeutics | 407.30M |
| Cerus | 406.76M |
| Alto Neuroscience | 402.99M |
| Precigen | 401.35M |
| AxoGen | 398.59M |
| enGene Holdings | 397.05M |
| Organogenesis Holdings | 384.46M |
| Revance Therapeutics | 379.67M |